Haleon's Advil lost share in its battle with Kenvue's Tylenol. The company's fighting back with "strong promotional plans" for the brand, says CEO.

Haleon has cut its annual revenue growth forecast after its first-half growth missed expectations due to a slowdown in demand for its healthcare products in North America. The British company reported ...

Good morning, everyone, and welcome to Haleon's Half Year 2025 Results Q&A Conference Call. I'm Jo Russell, Head of Investor Relations, and I'm joined this morning by Brian McNamara, our Chief ...

(Alliance News) - Haleon PLC said on Thursday reported higher profit in the first half, but cut its full-year outlook after revenue took a hit from mergers & acquisitions and slower trading in North ...

Consumer healthcare company Haleon hiked its interim dividend and raised its FY profit outlook on Wednesday after posting increased adjusted operating profits for H1, driven by productivity gains and ...

British consumer healthcare group Haleon cut its annual revenue growth forecast on Thursday after first-half growth missed ...

Brian McNamara​​, chief executive of of Haleon said the company is "quite optimistic about emerging market growth," whilst ...

Haleon CEO Brian McNamara discusses its 2025 half-year earnings and the impact of the macroeconomic headwinds on the business ...

Sensodyne-maker Haleon has cut its growth forecast for the year, blaming weak consumer sentiment in the US. The consumer ...

Sensodyne, the toothpaste first marketed in 1961 to reduce the pain of sensitive teeth, is among premium brands on sale in pharmacies and drug stores around the world. But if you live in an Indian ...